Ryan Turley, MD
Vascular Surgery · Austin, TXNPI 1245407469
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (60.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Medtronic at 51.7% of the total. Reporting peaked in 2023 at $6,600 and has fallen 54.8% since, to $2,986 in 2025.
Across 262 payments — averaging $98.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$13K
- W. L. Gore & Associates, Inc.$2K
- Bolton Medical Inc$2K
- Silk Road Medical, Inc.$1K
- Cvrx, Inc.$1K
- Inari Medical, Inc.$796
- plus $5K from 22 others
Across 8 payments — averaging $3554.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$22K
- Bolton Medical Inc$6K
What the payments were for
- Speaking & faculty fees$1,7007%
- Travel & lodging$8,52333%
- Food & beverage$15,43660%
- Education$820%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 65 | $13,318 |
| W. L. Gore & Associates, Inc. | 29 | $2,149 |
| Bolton Medical Inc | 31 | $1,728 |
| Silk Road Medical, Inc. | 21 | $1,459 |
| Cvrx, Inc. | 14 | $1,443 |
| Inari Medical, Inc. | 3 | $796 |
| Cook Medical LLC | 23 | $684 |
| Penumbra, Inc. | 5 | $529 |
| Endologix LLC | 4 | $441 |
| Johnson & Johnson | 4 | $410 |
| Bard Peripheral Vascular, Inc. | 13 | $367 |
| Boston Scientific | 6 | $353 |
| Shockwave Medical, Inc | 2 | $301 |
| Cardiovascular Systems Inc. | 14 | $244 |
| Smith+Nephew | 2 | $210 |
| Shape Memory Medical Inc. | 3 | $185 |
| Atricure, Inc. | 1 | $177 |
| Philips North America LLC | 6 | $161 |
| Terumo Medical Corporation | 2 | $151 |
| Abbott | 4 | $148 |
| BD | 1 | $131 |
| Osiris Therapeutics Inc. | 1 | $93 |
| Intuitive Surgical | 1 | $91 |
| Inspiremd Ltd | 1 | $62 |
| Ossur Americas, Inc. | 3 | $47 |
| Getinge USA Sales, LLC | 1 | $28 |
| Angiodynamics, Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$10,964
- Barostim Neo System$1,277
- ENROUTE Transcarotid Neuroprotection System$1,095
- ENROUTE Transcarotid Stent$803
- FLOWTRIEVER CATHETER, S$796
- CT THROMBECTOMY SYSTEM KIT$796
- Relay Grafts$739
- Indigo System$389
- Heli-FX EndoAnchor System$347
- ENHANCE Transcarotid Peripheral Access Kit$302
- EXCLUDER AAA Endoprosthesis$247
- Grafts$240
- STRATAFIX$220
- GORE VIABAHN VBX Balloon Expandable Endo$216
- ENDOCROSS Device$204
- Torus Stent Graft System$204
- PICO Single Use Negative Pressure Wound Therapy$200
- ENROUTE .014 Guidewire$190
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$188
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$180
How this compares
$25,740 in reported general payments places this provider in the 75th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $9,737 |
| ClopidogrelClopidogrel Bisulfate | 96 | $1,127 |
| Cilostazol | 31 | $723 |
| Rosuvastatin Calcium | 11 | $214 |
| Gabapentin | 17 | $199 |
| Tramadol Hcl | 22 | $44 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Austin
- Mazin FotehAustin$1.6M
- Pedro TeixeiraAustin$40K
- Stephen SettleAustin$37K
- Gregory PearlDallas$2.3M
- Alan LumsdenHouston$742K
- Stephen HohmannDallas$499K
- Michael SiahDallas$392K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Carlos TimaranDallas$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.